Mupirocin: Difference between revisions
(Remove disease-specific dosing covered by dynamic SMW tables) Tag: Reverted |
(Remove disease-specific entries now covered by AntibioticDose (3 sections)) Tag: Reverted |
||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
| Line 23: | Line 21: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 11:08, 20 March 2026
General
- Type: Antibiotic, Topical
- Dosage Forms: 2% cream, ointment
- Routes of Administration: topical
- Common Trade Names: Bactroban, Centany
Adult Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Balanoposthitis | cream BID | Antibacterial |
| Impetigo | 2% ointment q8hrs x 5 days | For nonbullous impetigo, topical antibiotics are as effective as oral antibiotics |
Pediatric Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Impetigo | 2% ointment applied TID x 5 days | Pediatric Topical |
Special Populations
- Pregnancy Rating: B
- Lactation risk: probably safe
Renal Dosing
- Adult: NA
- Pediatric: NA
Hepatic Dosing
- Adult: NA
- Pediatric: NA
Contraindications
- Allergy to class/drug
- large open wounds
- caution if renal impairment, mod-severe
Adverse Reactions
Serious
- hypersensitivity run
- anaphylaxis
- C. difficile-assoc diarrhea
- superinfection (prolonged use)
Common
- nausea
- burning
- headache
- pruritus
- pain
- stinging
Pharmacology
- Half-life: 20-40 min
- Metabolism: liver; CYP450; <0.3% systemic absorption
- Excretion: urine <3%
- Mechanism of Action: bacteriostatic or bactericidal, depending on susceptibility and concentration; reversibly binds to isoleucyl-tRNA synthetase, inhibiting protein synthesis (monoxycarbolic acid)